important information for the patient.
Luivac is an immunostimulating medicine used orally.
Antigenic structures present in Luivac are absorbed by the mucous membrane of the gastrointestinal tract and enter the cells of the immune system in the gastrointestinal tract area. This leads to the stimulation of defense mechanisms throughout the immune system of the mucous membranes, including the bronchial tree.
Indications for use:
Adults
Prevention of recurrent respiratory tract infections (RTI) in adults.
Children and adolescents
Prevention of recurrent respiratory tract infections (RTI) in children from 4 years of age.
Due to insufficient experience and the possibility of complex interactions, the medicine should not be used
in people with autoimmune diseases.
Before starting to take Luivac, you should discuss it with your doctor or pharmacist.
It is not recommended to take Luivac to prevent pneumonia, as there are no data from clinical trials confirming such an effect.
As with any non-specific immunotherapy, it is not recommended to use specific vaccinations at the same time.
Luivac should not be given to children under 4 years of age.
You should tell your doctor or pharmacist about all medicines the patient is taking or has recently taken, as well as any medicines the patient plans to take.
No interactions with other medicines have been found.
In patients undergoing immunosuppressive treatment, the response to vaccination may be weakened.
Tablets should be swallowed on an empty stomach, with a small amount of liquid.
If the patient is pregnant or breastfeeding, thinks she may be pregnant, or plans to have a child, she should consult a doctor or pharmacist before taking this medicine. Due to the lack of data, the medicine should not be used in pregnant women.
No contraindications to the use of Luivac during breastfeeding.
Luivac does not affect the ability to drive and use machines.
This medicine should always be taken according to the doctor's or pharmacist's recommendations. In case of doubts, you should consult a doctor or pharmacist.
The recommended dose is
Luivac should be taken for 28 consecutive days in two cycles separated by a 28-day break.
Tablets should be swallowed on an empty stomach, with a small amount of liquid.
Taking Luivac usually starts during a period free from infection. In the case of an acute infection, Luivac may be used at the same time as antibiotics, but it cannot replace anti-inflammatory treatment.
No cases of overdose have been reported.
You should not take a double dose to make up for a missed dose of Luivac.
If you have any further doubts about the use of this medicine, you should consult a doctor or pharmacist.
Like all medicines, Luivac can cause side effects, although not everybody gets them.
Uncommon (may affect up to 1 in 100 people)
Very rare (may affect up to 1 in 10,000 people)
If you experience any side effects, including any not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products,
Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Protect from light.
Do not use this medicine after the expiry date stated on the packaging.
The expiry date refers to the last day of the specified month.
Medicines should not be disposed of via wastewater or household waste containers. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
1 tablet contains:
bacterial lysate of each of the following strains 3 mg
(each strain at least 1 x 10 microorganisms)
Staphylococcus aureus
Streptococcus mitis
Streptococcus pyogenes
Streptococcus pneumoniae
Klebsiella pneumoniae
Moraxella (Branhamella) catarrhalis
Haemophilus influenzae
Other ingredients are: mannitol, microcrystalline cellulose, sodium carboxymethylcellulose (type A),
magnesium stearate, anhydrous colloidal silica.
PVC-Al-PVC/Al blisters in a cardboard box.
Packages contain 28 tablets (2 blisters) or 56 tablets (4 blisters).
To obtain more detailed information, you should contact the marketing authorization holder or the parallel importer.
Labormed Pharma S.A.
Bd. Theodor Pallady nr. 44B, Sector 3
Bucharest, Romania
DAIICHI SANKYO EUROPE GmbH
Luitpoldstrasse 1, 85276 Pfaffenhofen/iim
Germany
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Authorization number in Romania, the country of export:4595/2012/01
4595/2012/02
Parallel import authorization number:79/24
Translation of day of the week symbols on each tablet on the immediate packaging:
Lu -Monday
Ma -Tuesday
Mi -Wednesday
Jo -Thursday
Vi -Friday
Sâ -Saturday
Du –Sunday.
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.